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Abstract
IntroductionKnowledge of independent prognos-tic factors in patients with head and neck squamous cell carcinoma is important for appropriate treatment decisions. Given the availability of aggressive therapeutic options with known side effects and burdens for the patient, choosing the correct treatment option is vital.
Materials and methodsUsing a retrospective database of pa-tients treated over a 10-year period, independent prognostic factors for disease-free survival and overall sur-vival were assessed. Univariate anal-
ysis was used to identify significant variables, and multivariate Cox regres-sion analysis was used to determine independent prognostic factors.
ResultsBetween 1 January 1999 and 31 December 2009, 291 patients with head and neck squamous cell carcino-mas were analysed to identify prognos-tic factors for disease-free survival and overall survival. Although univariate 
analysis identified several significant factors, multivariate Cox regression analysis showed that capsule pene-tration and lymph node ratio were the 
only significant factors for disease-free survival and overall survival.
ConclusionLymph node ratio is an independent predictor of survival and should be examined in every patient undergoing neck dissection. Capsule penetration 
Lymph node ratio and capsule penetration as independent risk 
factors in head and neck squamous cell carcinomaM Lanzer1*, A Kruse1, HT Lübbers1, W Zemann1, S Reinisch2
of lymph nodes was another inde-pendent prognostic factor. In cases of capsule penetration or inappropriate lymph node ratio, adjuvant therapies are necessary.
IntroductionThe importance of tumour stage in disease-free survival (DFS) and over-all survival (OS) in patients with head and neck squamous cell carcinoma (SCC) is well known1–3. Tumour loca-tion4,5, grade6 and histological aspects such as perineural invasion7 and capsule penetration8 have been asso-ciated with poorer DFS and OS. Nevertheless, some aspects of tumour biology and patient survival remain unclear. Given the availability of ag-gressive therapies and their known side effects, selection of patients who require aggressive treatment has be-come important.In this study, we evaluated inde-pendent prognostic risk factors for DFS and OS in patients with SCC of the head and neck. We hypothesise that certain attributes lead to a poorer prognosis, whereas other attributes are unimportant.
Materials and methods
Study designWe developed a retrospective patient database.
Study sampleThe study population was derived from patients who presented at the Department of Otorhinolaryngology and Head and Neck (ENT) at the Medical University Hospital Graz for treatment of head and neck SCC be-tween 1 January 1999 and 31 December 2009. The study was ap-proved by the institutional ethics committee.
Inclusion criteria included the di-agnosis of SCC in the head and neck region and operative treatment at the primary tumour site with/without adjacent adjuvant radiotherapy or radiochemotherapy. Subjects were 
excluded if they had histological find-ings other than SCC, distant metasta-sis before neck dissection (ND) or were treated primarily outside the ENT department.
Study variablesVariables examined were age and sex; tumour location, stage, size and grade; neck lymph node status; histo-logical factors [blood vessel invasion (hemangiosis), lymph vessel invasion (lymphangiosis), capsule penetration, perineural invasion and conglomer-ate lymph nodes]; resection margin; number of positive lymph nodes; lymph node ratio and adjuvant therapy (postoperative chemotherapy and/or adjuvant radiotherapy). Treatment 
algorithm was defined (Table 1).
Point of interest
• Bivariate analysis to identify factors 
significantly affecting DFS and OS.
• Multivariate analyses of signifi-cant factors to identify indepen-dent prognostic factors.
Data collection, management and 
analysesData were collected and processed by building a database of information about the patient (sex, age), tumour (location, size and lymph node sta-tus), operation (date, type of resec-tion, resection margin, type of ND, number of levels excised, number of lymph nodes excised, number of positive lymph nodes, excision of non-lymphatic structures), histopatholog-
ical diagnostic findings (hemangiosis, 
* Corresponding author
Email: martin.lanzer@usz.ch1  University Hospital of Zurich, Clinic for Cranio-Maxillofacial Surgery, Frauenklinikstrasse 24, CH-8091 Zürich, Switzerland2  University Hospital of Graz, Department of General Otorhinolaryngology, Head and Neck Surgery, Auenbruggerplatz 26/28, 8036 Graz
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lymphangiosis, capsule penetration and perineural invasion), post-operative therapy, second primary tumours, lo-cation and time of recurrence and OS. Patient data were analysed using SPSS software (SPSS Inc., Chicago, IL, USA).Descriptive statistics were com-puted for each variable. Bivariate Cox regression analysis was used for each variable and odds ratios (OR) and p values were calculated. Multivariate Cox regression analysis was used for each predictor variable (p < 0.05) 
identified as significant in univariate analysis. We used a forward step-wise (likelihood ratio) procedure.For the analysis of cut-off points for lymph node ratio, the ‘maximally selected rank statistic’ method of Lausen and Schumacher10 was used. Cut-off points with the highest diver-sity of groups were calculated.
ResultsIn total, 291 patients were included (Table 2). The mean age was 64 (range, 27–87) years. Most (82.8%) patients were men. The mean follow-up duration was 38 months (maxi-mum, 128 months). Most patients 
had a tumour in the oropharyngeal region (32%), followed by the oral cavity (25.4%), hypopharynx (16.8%), larynx (15.1%), unknown primary location (8.6%) and nasopharynx (2.1%). Most patients presented with a stage IV tumour (56%), followed by stage III (19.6%), stage II (13.7%) and stage I (10.7%). Regarding T-status, most patients presented with a T2 tu-mour (29.4%). Lymph node status was pN0 in 37.5% of patients, fol-lowed by pN2b in nearly 31% of pa-tients. Because patients with distant metastasis at diagnosis were excluded, all patients were in the M0 state.Tumour grade was dominated by patients with moderately (43.6%) or poorly (51.2%) differentiated tu-mours. Only a few patients presented with well-differentiated or undiffer-entiated tumours. Perineural inva-sion was seen in 7.9% of patients; the percentage of lymphangiosis, heman-giosis, capsule penetration and con-glomerate lymph nodes was 7.2%, 2.4%, 18.6% and 10.3%, respectively.
Operative success, defined as a negative resection margin (R0 resec-tion), was achieved in 78.4% of 
patients. R1 resection was achieved in 19.9% of patients and tumour re-section was macroscopically positive 
(R2 resection) in five (1.7%) patients. Forty-one (14.1%) patients under-went radical ND on the ipsilateral side. The largest proportion of pa-
tients was treated with modified radical ND (28.9%), followed by pos-terolateral (25.1%), selective (8.2%), supraomohyoidal (8.9%), expanded supraomohyoidal (8.2%), lateral se-lective (4.8%), suprahyoidal (1.0%) and expanded lateral selective (0.7%) 
NDs. At least five levels were exam-ined and dissected in 35.1% of pa-tients. Given the small number of patients who underwent bilateral ND, only a minority (16.8%) of patients 
underwent more than five levels of ND.Results of neck dissections demon-strated a pN0 situation in 37.5% of patients. One or 2–5 lymph nodes were positive in 26.5% and 26.5% of patients, respectively. In 9.6% of pa-
tients, more than five lymph nodes were affected. Nearly two thirds of patients had lymph node ratios (number of negative lymph nodes/total number of excised lymph nodes) 
Table 1 Treatment algorithm 
Procedure Dosage/agent
Tumour staging By the Interdisciplinary Tumour Board including:
– clinical examination
– ultrasound (2 examiners)
– CT-scan (if contraindication → MRI)
– X-ray of the lungs and ultrasound of abdomen 
– PET-CT in some patients
-
Operation Intention of complete resection of tumor in all patients -
Adjuvant 
radiotherapy if
Positive resection margin of primary tumour
Positive lymph node atatus
Tumour size T3 or T4
66 Gy dosage if positive resection margin
All others recived 60 Gy
Neck was radiated bilaterally 50 Gy
Adjuvant radio-
chemotherapy if
Perineural invasion
Capsule penetration 
Lymph node status higher than pN2a
Cisplation 100 mg/m2 on day 1, 22, 43 
If Cisplation was not possible (kidney 
malfunction or high age)
Calais-Scheme9 was used (Carboplation/5 FU)
Follow-up First 2 years every 3 month, next 3 years every 6 month
After 5 years follow-up was conducted yearly CT/MRI, 
ultrasound and X-ray was conducted yearly
-
CT, computed tomography; MRI, magnetic resonance imaging
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Table 2 Descriptive statistics of 291 patients
Attribute Number (%)  Mean SD Median Minimum Maximum
Age (yr) - 291 64.08 10.6 64 27 97
Follow-up (mo) - 291 38.39 32.6 27.2 0.1 128.3
Sex Male 241 (82.8) - - - - -
Localisation Oral cavity
Oropharynx
Nasopharynx
Hyopharynx
Larynx 
Unknown primary
74 (25.4)
93 (32.0)
6 (2.1)
49 (16.8)
44 (15.1)
25 (8.6)
- - - - -
TNM stage Stage I–II
Stage III–IV
71 (24.4)
220 (75.6)
- - - - -
Tumor stage T1–2
T3–4
Tx
150 (51.6)
116 (39.9)
25 (8.6)
- - - - -
Lymph node 
status
N0
N1
N2a
N2b
N2c
N3
109 (37.5)
38 (13.1)
28 (9.6)
90 (30.9)
15 (5.2)
11 (3.8)
- - - - -
Tumour grade Well/moderately-differentiated
Poorly/un-differentiated
137 (47.0)
154 (52.9)
- - - - -
Perineural 
invasion
No
Yes
268 (92.1)
23 (7.9)
- - - - -
Lymphangiosis No
Yes
270 (92.8)
21 (7.2)
- - - - -
Hemangiosis No
Yes
284 (97.6)
7 (2.4)
- - - - -
Capsule 
penetration
No
Yes
237 (81.4)
54 (18.6)
- - - - -
Conglomerate 
lymph nodes
No
Yes
261 (89.7)
30 (10.3)
- - - - -
Resection margin Negative
Positive
228 (78.4)
63 (21.6)
- - - - -
Number of 
positive lymph 
nodes
0
1
2–5
>5
109 (37.5)
77 (26.5)
77 (26.5)
28 (9.6)
- - - - -
Lymph nodes ratio 100%-94%
93%-87%
<87%
187 (64.3)
48 (16.5)
56 (19.2)
- - - - -
Lymph nodes ratio 
(neg/exc)[%]
- 291 91.96 13.0 96.3 0 100
Adjuvant therapy No 
Radiotherapy 
Chemotherapy 
Radiochemotheraphy
113 (38.8)
140 (48.1)
1 (0.3)
37 (12.7)
- -
SD, standard deviation
For citation purposes: Lanzer M, Kruse A, Lübbers HT, Zemann W, Reinisch S. Lymph node ratio and capsule penetration as 
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increased OS in patients with extra-capsular spread to 50% (27/54 pa-tients died during follow-up).Perineural invasion, another histo-logical aspect discussed as an inde-pendent prognostic factor, was not 
found to be significant in this multi-variate analysis. Previous reports have indicated that perineural invasion is a strong predictor for local and locore-gional recurrence, and thus should be included in pathological examina-tions7 and treated with adjuvant ther-apy2. In cutaneous cancer of the head and neck, perineural invasion is also a predictive factor for survival. In our study, perineural invasion was identi-
fied as significant in univariate analy-ses (p = 0.031 for DFS and p = 0.034 for OS), but it was not an indepen-dent prognostic factor in multivariate 
analysis. These findings are impor-tant because most data supporting associations between perineural in-vasion and outcome have been de-rived from univariate analyses7.Lymph node ratio was the second independent prognostic factor. Previ-ous studies have demonstrated that this variable is an important diag-nostic tool in certain tumours, such as gastric16–18, endometrial19, colorec-tal20–22 and pancreatic23,24 cancers. To our knowledge, only three reports have investigated lymph node ratio as a prognostic tool in head and neck cancer. Shrime et al.25 suggested that the ratio between the number of ex-cised and that of positive lymph nodes was a predictive factor for outcome. In an investigation of 386 patients with oral SCCs, Gil et al.26 reached the same conclusion. Shrime et al.24 used two cut-off points (6%, 13%), whereas Gil et al.25 used only 6%. Both studies obtained similar results and demon-
strated significant effects of lymph node ratio on DFS and OS. Suslu et al.27 reached the same conclusion about the importance of lymph node ratio, using 4% as the cut-off value for a 
significant difference in outcome.The present study used a method for calculating cut-off points (the 
<87%. The OR for a lymph node ratio of <94% was 1.698 (p = 0.023) and that for a ratio of <87% was 2.271 (p < 0.001). The OR for an event was 1.693-fold higher when capsule penetration was evident than when the capsule was intact (p = 0.014).Multivariate analysis for OS 
(Table 4) identified the same inde-pendent predictors as for DFS. The ORs for lymph node ratio were 2.269 and 2.904 for 93–87% and <87%, respectively, compared with the refer-ence (100–94%). The OR for capsule penetration was 1.886 (p = 0.009).
DiscussionIn the data analysis of 291 patients with head and neck SCC, two vari-ables were found to be independent prognostic factors in multivariate 
analyses: lymph node ratio and cap-sule penetration. The impact of cap-sule penetration on locoregional DFS and OS is well known8,11,12. Even in pa-tients with clinically negative necks, occult metastases with capsule pene-tration occur13, putting the patient at high-risk of undertreatment. This 
finding also disproves the former idea that extracapsular spread was associated with larger lymph node 
metastases and fixed lymph nodes14.In an investigation of 266 patients with SCC of the tongue, Myers et al.15 reported 5-year OS rates for patients with pathological node-negative necks, node-positive necks without extracap-sular spread and node-positive necks with extracapsular spread of 75%, 50% and 30%, respectively. Despite postoperative radiotherapy in 89% of patients with extracapsular spread, the regional failure rate was 29%. Thus, the authors concluded that fur-ther adjuvant therapy was necessary for regional and distant control and improved survival.Our data suggests the importance of extracapsular spread for DFS and OS. Of seven patients with extracapsular spread who received no adjuvant ther-apy, six (85.7%) died during follow-
up. Adjuvant therapy significantly 
exceeding 94%. In total, 113 (39.2%) patients received no adjuvant ther-apy, 140 (48.1%) patients received radiotherapy, 12.7% received com-bined radiochemotherapy and one received chemotherapy alone.Two-thirds of patients experienced no recurrence during follow-up. Recurrence was observed in 98 (33.7%) cases; distant metastasis occurred in 34 of these patients. In total, 155 (53.3%) patients were disease free after follow-up, 13.7% of patients suffered recur-rence but survived follow-up, 19.9% of patients died after recurrence and 13.1% died of other causes. In total, 195 patients survived follow-up.
Univariate analysis identified the 
following factors as significantly af-
fecting DFS: age, tumour location, stage, pT status, pN status, perineural invasion, lymphangiosis, hemangiosis, capsule penetration, conglomerate lymph nodes, resection margin, num-ber of positive excised lymph nodes and lymph node ratio (Table 3). The 
highest level of significance was found for capsule penetration and lymph node ratio (p < 0.001), followed by conglomerate lymph nodes, lymphan-giosis and positive resection margin.
Univariate analysis identified the 
following factors as significantly af-
fecting OS: age, tumour location, stage, pT status, pN status, perineural invasion, lymphangiosis, hemangio-sis, capsule penetration, conglomer-ate lymph nodes, resection margin, number of positive excised lymph node, and lymph node ratio (Table 4). 
OS also significantly differed accord-ing to the use of adjuvant radiother-
apy. The highest level of significance was obtained for capsule penetra-tion, conglomerate lymph nodes, pN status and lymph node ratio (p < 0.001), followed by hypopharyngeal location and overall staging.Multivariate analysis revealed two independent predictor variables for 
DFS: lymph node ratio and capsule penetration (Table 3). Lymph node 
ratio was divided into three groups: 100–94% (reference), 93–87% and 
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Table 3 Disease-free survival (bivariate and multivariate analyses) 
Variable Reference 
category
n Reference Risk for n Risk OR 95% CI 
LB
95% CI 
UB
p values
Age - - Increase of 1 year 1.018 1.002 1.035 0.031
Oral cavity/oropharynx Other 
tumor sites
124 Oral cavity/
oropharnyx
167 0.709 0.506 0.992 0.046
Hypopharyngeal 
cancer
Other 
tumor sites
242 Hypopharyngeal 
cancer
49 1.554 1.036 2.333 0.333
Stage -
Stage I
Stage I
Stage I
-
31
31
31
-
Stage II
Stage III
Stage IV
-
40
57
163
-
1.198
2.341
2.476
-
0.512
1.107
1.240
-
2.806
4.951
4.946
0.010
0.677
0.026
0.010
pT status -
T1
T1
T1
T1
-
64
64
64
64
-
T2
T3
T4
Tx
-
86
68
48
25
-
1.446
1.836
2.546
2.516
-
0.857
1.059
1.472
1.259
-
2.440
3.183
4.403
5.027
0.007
0.168
0.030
0.001
0.009
pN status -
N0
N0
N0
N0
N0
-
109
109
109
109
109
-
N1
N2a
N2b
N2c
N3
-
38
28
90
15
11
-
1.890
0.863
1.840
2.134
2.555
-
1.141
0.419
1.203
1.034
1.139
-
3.132
1.779
2.813
4.404
5.730
0.009
0.013
0.690
0.005
0.040
0.023
Perineural invasion No 268 Yes 23 1.842 1.057 3.210 0.031
Lymphangiosis No 270 Yes 21 2.212 1.290 3.793 0.004
Hemangiosis No 284 Yes 7 2.559 1.042 6.286 0.040
Capsule penetration No 237 Yes 54 2.290 1.554 3.375 <0.001
Conglomerate lymph 
nodes
No 261 Yes 30 2.253 1.425 3.563 0.001
Resection margin -
R0
R0
-
228
228
-
R1
R2
-
58
5
-
1.713
3.098
-
1.162
1.132
-
2.525
8.479
0.004
0.007
0.028
Positive lymph nodes pN0 109 pN+ 182 1.720 1.189 2.487 0.004
Positive lymph nodes All (Range 
0–40)
n = 291 Increase of 1 positive lymph 
node
1.038 1.011 1.066 0.005
Positive lymph nodes -
0
0
0
-
109
109
109
-
1
2–5
>5
-
77
77
28
-
1.395
1.885
2.375
-
0.890
1.218
1.361
-
2.185
2.916
4.144
0.005
0.147
0.004
0.002
Lymph node ratio [%] Decrease of 1% 1.022 1.012 1.031 <0.001
Lymph node ratio -
100%-94%
100%-94%
-
187
187
-
93%-87%
<87%
-
48
56
-
1.926
2.678
-
1.241
1.795
-
2.991
3.996
<0.001
0.003
<0.001
(Contd)
For citation purposes: Lanzer M, Kruse A, Lübbers HT, Zemann W, Reinisch S. Lymph node ratio and capsule penetration as 
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Model: Multivariate Cox regression
All significant variables from 
univariate analysis included
Risk for OR 95% CI LB 95% CI UB p values
Lymph node ratio
 
 
-
93%-87% vs 100%-94%
<87% vs 100%-94%
-
1.698
2.271
-
1.077
1.482
-
2.678
3.482
0.001
0.023
<0.001
Capsule penetration Yes vs No 1.693 1.114 2.572 0.014
CI, confidence interval; LB, lower bound; n, number (patients); R1, microscopically positive resection margin; R2, macroscopically positive resection margin; 
Reference, patients referred to; Risk, patients at risk; UB, upper bound
Table 4 Overall survival (bivariate and multivariate Cox regression analyses)
Variable Reference 
category
n 
Reference
Risk for n  
Risk
OR 95% CI LB 95% CI UB p values
Age Increase of 1 year 1.020 1.000 1.040 0.046
Oral cavity/oropharynx Other tumour 
sites
124 Oral cavity/
oropharynx
167 0.637 0.426 0.951 0.027
Hypopharyngeal cancer Other tumour 
sites
242 Hypopharyngeal 
cancer
49 2.142 1.371 3.347 0.001
Localisation -
Oral cavity
Oral cavity
Oral cavity
Oral cavity
Oral cavity
-
74
74
74
74
74
-
Oropharynx
Nasopharynx
Hypopharynx
Larynx
Unknown primary
-
93
6
49
44
25
-
1.040
0.985
2.298
1.249
1.126
-
0.578
0.229
1.276
0.634
0.449
-
1.873
4.236
4.137
2.459
2.821
0.041
0.896
0.984
0.006
0.520
0.801
Staging -
Stage I
Stage I
Stage I
-
31
31
31
-
Stage II
Stage III
Stage IV
-
40
57
163
-
1.608
3.336
4.408
-
0.484
1.132
1.601
-
5.345
9.829
12.138
0.002
0.438
0.029
0.004
Staging T
 
 
 
 
-
T1
T1
T1
T1
-
64
64
64
64
-
T2
T3
T4
Tx
-
86
68
48
25
-
1.313
1.573
2.509
1.304
-
0.72
0.82
1.345
0.512
-
2.392
3.017
4.681
3.321
0.045
0.374
0.173
0.004
0.578
Staging N
 
 
 
 
 
-
N0
N0 
N0
N0
N0
-
109
109
109
109
109
-
N1 
N2a
N2b 
N2c 
N3
-
38
28
90
15
11
-
2.104
0.608
2.216
2.697
4.756
-
1.140
0.212
1.329
1.167
2.041
-
3.884
1.748
3.696
6.232
11.083
<0.001
0.017
0.356
0.002
0.020
<0.001
Perineural invasion No 268 Yes 23 1.984 1.054 3.734 0.034
Lymphangiosis No 270 Yes 21 2.602 1.415 4.784 0.002
Hemangiosis No 284 Yes 7 3.422 1.241 9.433 0.017
Capsule penetration No 237 Yes 54 2.821 1.810 4.396 <0.001
Conglomerate lymph 
nodes
No 261 Yes 30 2.938 1.771 4.874 <0.001
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The combined use of nodal yield and lymph node ratio should inform the surgeon about the risk of encoun-tering additional positive lymph nodes and may be a useful prognostic tool in the treatment of head and neck SCC.
Abbreviations listDFS, disease-free survival; ND, neck dissection; OS, overall survival; SCC, squamous cell carcinoma.
References1. Chen YK, Huang HC, Lin LM, Lin CC. 
Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. 
Oral Oncol. 1999 Mar;35(2):173–9.
node was positive. DFS and OS in these patients were similar to those in patients with a negative neck. In contrast, the recurrence rate was high in patients who underwent selective ND procedures, especially those who were thought to have negative neck status. Another reason for our calcu-lation of negative instead of positive lymph nodes was the likelihood that ‘the next excised lymph node’ would also be negative; thus, this type of calculation is more accurate.Ebrahimi et al.28 also described the importance of adequate ND, demon-strating that nodal yield was an inde-pendent prognostic factor in patients with oral SCC undergoing elective ND. 
‘maximally selected rank statistic’ method) as described by Lausen and Schumacher10 and applied by Shrime et al.24. However, instead of defining lymph node ratio as positive lymph nodes/all excised lymph nodes, we used the percentage of negative lymph nodes/all excised lymph nodes. This technique allowed us to include all patients with negative lymph node status. This method was used for two reasons. First, our lymph node status 
data demonstrated no significant dif-ference between pN0 and pN1 status. In particular, patients who underwent extensive ND and excision of a large number of lymph nodes had good prognostic outcomes if only one lymph 
Table 4 Continued
Variable Reference 
category
n 
Reference
Risk for n  
Risk
OR 95% CI LB 95% CI UB p values
Resection margin -
R0
R0
-
228
228
-
R1
R2
-
58
5
-
1.987
5.468
-
1.259
1.960
-
3.138
15.254
<0.001
0.003
0.001
Positive lymph nodes All  
(Range 0–40)
n = 291 Increase of 1 
LKpos
 1.055 1.026 1.084 <0.001
Positive lymph nodes w/o 0  
(Range 1–40)
n = 182 Increase of 1 
LKpos
 1.041 1.009 1.075 0.013
Positive lymph nodes -
0 = 0
0 = 0
0 = 0
-
109
109
109
-
1
2–5
>5
-
77
77
28
-
1.336
2.405
3.361
-
0.755
1.428
1.796
-
2.361
4.052
6.287
<0.001
0.320
0.001
<0.001
Lymph node ratio (%)   Increase of 1%  1.024 1.014 1.035 <0.001
Lymph nodes Negative 109 Positive 182 2.021 1.285 3.180 0.002
Lymph node ratio -
100%-94%
100%-94%
-
187
187
-
93%-87%
<87%
-
48
56
-
2.617
3.561
-
1.561
2.232
-
4.387
5.682
<0.001
<0.001
<0.001
Adjuvant radiotherapy No 114 Yes 177 1.548 1.010 2.374 0.045
Model: Multivariate Cox regression
All significant variables from 
univariate analysis included
Risk for OR 95% CI LB 95% CI UB p values
Lymph node ratio -
93%-87% vs 100%-94%
<87% vs 100%-94%
-
2.269
2.904
-
1.331
1.761
-
3.867
4.789
<0.001
0.003
<0.001
Capsule penetration Yes vs No 1.886 1.169 3.043 0.009
CI, confidence interval; LB, lower bound; n, number (patients); R1, microscopically positive resection margin; R2, macroscopically positive resection margin; 
Reference, patients referred to; Risk, patients at risk; UB, upper bound
For citation purposes: Lanzer M, Kruse A, Lübbers HT, Zemann W, Reinisch S. Lymph node ratio and capsule penetration as 
independent risk factors in head and neck squamous cell carcinoma. Head Neck Oncol. 2012 Dec 29;4(5):89.
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